4CPS-280 Benefits of pharmacokinetic estimation of methotrexate levels in paediatric osteosarcoma patients

H. R. Ramallo, N. Gutiérrez, C. A. Vayo, M. Moreno
{"title":"4CPS-280 Benefits of pharmacokinetic estimation of methotrexate levels in paediatric osteosarcoma patients","authors":"H. R. Ramallo, N. Gutiérrez, C. A. Vayo, M. Moreno","doi":"10.1136/EJHPHARM-2021-EAHPCONF.112","DOIUrl":null,"url":null,"abstract":"Background and importance Monitoring of methotrexate serum levels in osteosarcoma paediatric patients includes estimation of serum levels of methotrexate 24 hours after initiation of the infusion ([MTX24h]), which allows folinic acid rescue to be started at adjusted doses. When pharmacokinetic estimation is not possible, the standard rescue (15 mg/m2/6 hours) is recommended and subsequently adjusted according to the real [MTX24h]. Aim and objectives To evaluate the correlation and concordance of the estimated and real [MTX24h], and the benefits of the estimation in comparison with the dosage by protocol. Material and methods A retrospective study of paediatric patients treated with 12 g/m2 methotrexate monitored by the pharmacy department from January 2014 to June 2020 was conducted. Estimated [MTX24h] was determined with a Bayesian model with PKS software. Variables collected were age, sex, number of cycles received, estimated and real [MTX24h] and folinic rescue dose. Pearson and intraclass correlation coefficients between real and estimated [MTX24h] were calculated. The agreement between the dosage of folinic acid by protocol and by estimating [MTX24h] was assessed with the Cohen kappa coefficient. Results 23 patients, 56.5% (13) men, median age 14 (4–17) years, received 152 cycles of methotrexate. The median number of cycles per patients was 8 (2–8). Median estimated [MTX24h] was 7 (2–80) and real [MTX24h] was 8 (1–85). The Pearson’s correlation coefficient and intraclass correlation coefficient for real and estimated [MTX24h] were r=0.949 and CCI=0.974, respectively, indicating a high linear correlation and concordance between the two. In 71.8% (94) of the cycles, the estimated folinic rescue matched with the dose which the patient should receive according to real [MTX24h]. Assuming the dosing of folinic acid at 24 hours by protocol (15 mg/m2/6 hours) in all cases, only 35.1% (46) of patients would have received the correct dose. The Cohen kappa between the two methods was 0.189, indicating only slight agreement between both methods in favour of estimating [MTX24h]. Conclusion and relevance Estimated and real [MTX24h] showed high correlation and concordance, and in most cases the folinic acid rescue dose was correctly administered based on the estimated [MTX24h]. These results seem to indicate that the estimation of [MTX24h] and posterior estimation of folinic acid rescue are superior to systematic administration of 15 mg/m2/6 hours. References and/or acknowledgements Conflict of interest No conflict of interest","PeriodicalId":11998,"journal":{"name":"European Journal of Hospital Pharmacy","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background and importance Monitoring of methotrexate serum levels in osteosarcoma paediatric patients includes estimation of serum levels of methotrexate 24 hours after initiation of the infusion ([MTX24h]), which allows folinic acid rescue to be started at adjusted doses. When pharmacokinetic estimation is not possible, the standard rescue (15 mg/m2/6 hours) is recommended and subsequently adjusted according to the real [MTX24h]. Aim and objectives To evaluate the correlation and concordance of the estimated and real [MTX24h], and the benefits of the estimation in comparison with the dosage by protocol. Material and methods A retrospective study of paediatric patients treated with 12 g/m2 methotrexate monitored by the pharmacy department from January 2014 to June 2020 was conducted. Estimated [MTX24h] was determined with a Bayesian model with PKS software. Variables collected were age, sex, number of cycles received, estimated and real [MTX24h] and folinic rescue dose. Pearson and intraclass correlation coefficients between real and estimated [MTX24h] were calculated. The agreement between the dosage of folinic acid by protocol and by estimating [MTX24h] was assessed with the Cohen kappa coefficient. Results 23 patients, 56.5% (13) men, median age 14 (4–17) years, received 152 cycles of methotrexate. The median number of cycles per patients was 8 (2–8). Median estimated [MTX24h] was 7 (2–80) and real [MTX24h] was 8 (1–85). The Pearson’s correlation coefficient and intraclass correlation coefficient for real and estimated [MTX24h] were r=0.949 and CCI=0.974, respectively, indicating a high linear correlation and concordance between the two. In 71.8% (94) of the cycles, the estimated folinic rescue matched with the dose which the patient should receive according to real [MTX24h]. Assuming the dosing of folinic acid at 24 hours by protocol (15 mg/m2/6 hours) in all cases, only 35.1% (46) of patients would have received the correct dose. The Cohen kappa between the two methods was 0.189, indicating only slight agreement between both methods in favour of estimating [MTX24h]. Conclusion and relevance Estimated and real [MTX24h] showed high correlation and concordance, and in most cases the folinic acid rescue dose was correctly administered based on the estimated [MTX24h]. These results seem to indicate that the estimation of [MTX24h] and posterior estimation of folinic acid rescue are superior to systematic administration of 15 mg/m2/6 hours. References and/or acknowledgements Conflict of interest No conflict of interest
小儿骨肉瘤患者甲氨蝶呤水平药代动力学评估的益处
背景和重要性监测骨肉瘤儿童患者的甲氨蝶呤血清水平包括开始输注后24小时([MTX24h])甲氨蝶呤血清水平的估计,这允许以调整剂量开始叶酸抢救。当无法进行药代动力学估计时,建议采用标准抢救(15 mg/m2/6小时),并根据实际[MTX24h]进行调整。目的评价估计与实际[MTX24h]的相关性和一致性,并与方案剂量进行比较。材料与方法对2014年1月至2020年6月药房监测的12 g/m2甲氨蝶呤患儿进行回顾性研究。估计[MTX24h]用PKS软件的贝叶斯模型确定。收集的变量为年龄、性别、接受周期数、估计和实际[MTX24h]和亚叶酸拯救剂量。计算实值与估计值[MTX24h]之间的Pearson和类内相关系数。用Cohen kappa系数评价方案中叶酸用量与估算的[MTX24h]之间的一致性。结果23例患者,男性占56.5%(13例),中位年龄14(4-17)岁,接受了152个周期的甲氨蝶呤治疗。每位患者的中位周期数为8(2-8)。估计[MTX24h]中位数为7(2-80),实际[MTX24h]中位数为8(1-85)。real和estimated [MTX24h]的Pearson’s相关系数和class内相关系数分别为r=0.949和CCI=0.974,两者具有高度的线性相关和一致性。在71.8%(94个)周期中,根据实际[MTX24h],估计的叶酸挽救量与患者应接受的剂量相匹配。假设所有病例按方案在24小时给药叶酸(15 mg/m2/6小时),只有35.1%(46)的患者接受了正确的剂量。两种方法之间的Cohen kappa为0.189,表明两种方法之间只有轻微的一致,有利于估计[MTX24h]。估计[MTX24h]与实际[MTX24h]具有高度的相关性和一致性,在大多数情况下,根据估计[MTX24h]给药是正确的。这些结果似乎表明,估计[MTX24h]和后验估计亚叶酸抢救优于系统给药15 mg/m2/6小时。参考文献和/或致谢利益冲突无利益冲突
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信